According to the China Brain-Computer Interface Commercialization Outlook Report, published on April 1st, brain-computer interface (BCI) technology is on the cusp of a prime phase for widespread commercialization, fueled by industrial policies, technological advancements, and market demand. The year 2026 is anticipated to mark the inaugural year of its broad application. The report highlights that BCI technology has already laid the groundwork for large-scale deployment. Specifically, invasive BCI has reached a "near-commercialization" stage in clinical settings, with medical applications undergoing extensive clinical trials and early stages of industrialization. Meanwhile, non-invasive BCI products are also maturing in terms of their forms and functionalities.

Several institutions have projected the market size for BCI, and after a thorough assessment, the report predicts that China's BCI market will surpass RMB 5 billion by 2026 and could potentially exceed RMB 15 billion by 2030. During the "15th Five-Year Plan" period, the BCI industry chain is expected to undergo further integration, with leading industry players emerging. Giants from various sectors will enter the market, spurring mergers and acquisitions. Simultaneously, the industry will witness consolidation, with some teams or enterprises facing elimination.